Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma

Annals of Hematology

Volumn 86, Issue 9, 2007, Pages 631-638

  Cheung, Matthew C ^a,d   Imrie, Kevin R ^a   Leitch, Heather A ^b   Park Wyllie, Laura Y ^c   Buckstein, Rena ^a   Antoniou, Tony ^c   Loutfy, Mona R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

AIDS related lymphoma; Antiretroviral therapy; Chemotherapy; Diffuse large B cell lymphoma; Human immunodeficiency virus; Non Hodgkin's lymphoma; Rituximab; Survey methodology

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AIDS RELATED COMPLEX; AIDS RELATED LYMPHOMA; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANADA; CONFIDENCE INTERVAL; DRUG CHOICE; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PATIENT CARE; PHYSICIAN ATTITUDE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANADA; CHOICE BEHAVIOR; CYCLOPHOSPHAMIDE; DATA COLLECTION; DISEASE MANAGEMENT; DOXORUBICIN; HUMANS; LYMPHOMA, AIDS-RELATED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PREDNISONE; VINCRISTINE;

EID: 34547604548     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0284-8     Document Type: Article

References (30)

1. Palella FJ, Delaney KM, Moorman AC et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853-860
2. Cheung MC, Pantanowitz L, Dezube BJ (2005) AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 10(6):412-426
3. Mocroft A, Katlama C, Johnson AM et al (2000) AIDS across Europe, 1994-1998: The EuroSIDA study. Lancet 356:291-296
4. Levine AM (2003) AIDS-related lymphoma and Hodgkin's disease. ASH Education Book, pp 304-313
5. Hoffmann C, Wolf E, Faetkenheuer G (2003) Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 17:1521-1529
6. Ratner L, Lee J, Tang S et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171-2178
7. Little RF, Pittaluga S, Grant N et al (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: Impact of antiretroviral therapy suspension and tumor biology. Blood 101(12):4653-4659
8. Feugier P, Van Hoof A, Sebban C et al (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23(18):4117-4126
9. Kaplan LD, Lee JY, Ambinder RF et al (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin's lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106(5):1538-1543
10. BC Cancer Agency (2005) Cancer management guidelines-malignant lymphoma-3.4.9 AIDS related lymphomas. (Accessed March 9, 2007, at http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Lymphoma/HD/ 08AIDSRelatedLymphomas.htm)
11. Imrie K, Cheung MC, Haynes AE, Stevens A, Meyer R, Hematology Disease Site Group (2005) Rituximab in lymphoma and chronic lymphocytic leukemia: A clinical practice guideline. (Accessed March 9, 2007, at http://www.cancercare.on.ca/pdf/pebc6-8f.pdf)
12. Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, Cleary PD (2005) Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med 165(6):618-623
13. Buckstein R, Lim W, Franssen E, Imrie KL (2003) CNS prophylaxis and treatment in non-Hodgkin's lymphoma: Variation in practice and lessons from the literature. Leuk Lymphoma 44(6):955-962
14. Dillman DA (2000) Mail and internet surveys: The tailored design method, 2nd edn. Wiley, New York
15. Kaplan LD, Straus DJ, Testa MA (1997) Low-dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 336:1641-1648
16. Besson C, Goubar A, Gabarre J et al (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339-2344
17. Levine AM, Seneviratne L, Espina BM et al (2000) Evolving characteristics of AIDS-related lymphoma. Blood 96:4084-4090
18. Levine AM (2005) AIDS-related lymphoma. In: American society of clinical oncology virtual meeting
19. Antoniou T, Tseng AL (2005) Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet 44(2):111-145
20. Bower M, McCall-Peat N, Ryan N et al (2004) Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood 104(9):2943-2946
21. Dunleavy K, Little R, Gea-Banacloche J et al (2004) Abbreviated treatment with short-course dose-adjusted EPOCH and rituximab (DA-EPOCH-R) is highly effective in AIDS-related lymphoma (ARL). Blood 104(11):3111 (ASH Annual Meeting Abstracts)
22. Spina M, Jaeger U, Sparano JA et al (2005) Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: Pooled results from 3 phase 2 trials. Blood 105(5):1891-1897
23. Magrath I, Adde M, Shad A et al (1996) Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14(3):925-934
24. Mead GM, Sydes MR, Walewski J et al (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: Results of United Kingdom lymphoma group LY06 study. Ann Oncol 13(8):1264-1274
25. Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM (2005) AIDS-related Burkitt's lymphoma vs diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430-4438
26. Noy A (2006) Update in HIV lymphoma. Curr Opin Oncol 18(5):449-455
27. Boue F, Gabarre J, Gisselbrecht C et al (2006) Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 24(25):4123-4128
28. Dunleavy K, Wilson WH, Kaplan LD (2006) The case for rituximab in AIDS-related lymphoma. Blood 107(7):3014-3015
29. Menon D, Stafinski T, Stuart G (2005) Access to drugs for cancer: Does where you live matter? Can J Public Health 96(6):454-458
30. Ezzat H, Filipenko JD, Vickars LM et al (2005) BCL-2 expression may adverse affect outcome in HIV-associated systemic diffuse large B cell lymphoma. Blood 106(11):4674 (Abstract)